Single-Cell Analysis of Rohon-Beard Neurons Implicates Fgf Signaling in Axon Maintenance and Cell Survival.


Journal

The Journal of neuroscience : the official journal of the Society for Neuroscience
ISSN: 1529-2401
Titre abrégé: J Neurosci
Pays: United States
ID NLM: 8102140

Informations de publication

Date de publication:
17 Apr 2024
Historique:
received: 23 08 2023
revised: 18 01 2024
accepted: 18 02 2024
medline: 19 4 2024
pubmed: 1 3 2024
entrez: 29 2 2024
Statut: epublish

Résumé

Peripheral sensory neurons are a critical part of the nervous system that transmit a multitude of sensory stimuli to the central nervous system. During larval and juvenile stages in zebrafish, this function is mediated by Rohon-Beard somatosensory neurons (RBs). RBs are optically accessible and amenable to experimental manipulation, making them a powerful system for mechanistic investigation of sensory neurons. Previous studies provided evidence that RBs fall into multiple subclasses; however, the number and molecular makeup of these potential RB subtypes have not been well defined. Using a single-cell RNA sequencing (scRNA-seq) approach, we demonstrate that larval RBs in zebrafish fall into three, largely nonoverlapping classes of neurons. We also show that RBs are molecularly distinct from trigeminal neurons in zebrafish. Cross-species transcriptional analysis indicates that one RB subclass is similar to a mammalian group of A-fiber sensory neurons. Another RB subclass is predicted to sense multiple modalities, including mechanical stimulation and chemical irritants. We leveraged our scRNA-seq data to determine that the fibroblast growth factor (Fgf) pathway is active in RBs. Pharmacological and genetic inhibition of this pathway led to defects in axon maintenance and RB cell death. Moreover, this can be phenocopied by treatment with dovitinib, an FDA-approved Fgf inhibitor with a common side effect of peripheral neuropathy. Importantly, dovitinib-mediated axon loss can be suppressed by loss of Sarm1, a positive regulator of neuronal cell death and axonal injury. This offers a molecular target for future clinical intervention to fight neurotoxic effects of this drug.

Identifiants

pubmed: 38423763
pii: JNEUROSCI.1600-23.2024
doi: 10.1523/JNEUROSCI.1600-23.2024
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : UpdateOf

Informations de copyright

Copyright © 2024 the authors.

Déclaration de conflit d'intérêts

The authors declare no competing financial interests.

Références

J Neurosci. 2015 Jan 14;35(2):559-70
pubmed: 25589751
J Neurosci. 2022 Aug 10;42(32):6195-6210
pubmed: 35840323
Methods Mol Biol. 2020;2148:195-202
pubmed: 32394383
Dev Dyn. 2007 Nov;236(11):3088-99
pubmed: 17937395
Neurology. 2019 Jul 9;93(2):e143-e148
pubmed: 31167931
Curr Opin Neurol. 2002 Oct;15(5):633-8
pubmed: 12352008
Nature. 2021 Feb;590(7844):129-133
pubmed: 33408418
Int J Dev Neurosci. 2007 May;25(3):155-64
pubmed: 17403595
Science. 2012 Jul 27;337(6093):481-4
pubmed: 22678360
Cell. 2003 Mar 21;112(6):819-29
pubmed: 12654248
Nat Commun. 2023 Jan 23;14(1):366
pubmed: 36690629
Front Neurosci. 2017 Aug 31;11:481
pubmed: 28912674
Mol Neurobiol. 2021 Aug;58(8):3884-3902
pubmed: 33860438
J Neurobiol. 2005 Mar;62(4):425-38
pubmed: 15547934
Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2115009119
pubmed: 35858442
Nat Genet. 2000 May;25(1):25-9
pubmed: 10802651
Commun Biol. 2020 Jan 30;3(1):49
pubmed: 32001778
Neuron. 2004 Mar 25;41(6):849-57
pubmed: 15046718
Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2859-64
pubmed: 25691753
Development. 2005 Dec;132(23):5173-83
pubmed: 16251209
Dev Biol. 2001 Nov 15;239(2):323-37
pubmed: 11784038
J Neurosci. 2008 Oct 1;28(40):10102-10
pubmed: 18829968
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Exp Neurol. 2021 Apr;338:113607
pubmed: 33460644
J Exp Zool. 1961 Nov;148:91-123
pubmed: 13904079
Dev Biol. 2020 Mar 15;459(2):100-108
pubmed: 31782996
Neuron. 2017 Feb 22;93(4):806-821.e9
pubmed: 28162808
Fundam Clin Pharmacol. 2015 Jun;29(3):310-5
pubmed: 25711853
Brain. 2016 Dec;139(Pt 12):3092-3108
pubmed: 27797810
Leuk Res. 2010 Feb;34(2):129-34
pubmed: 19783301
Target Oncol. 2015 Jun;10(2):199-213
pubmed: 25213039
Cancer Chemother Pharmacol. 2013 Mar;71(3):619-26
pubmed: 23228992
Dev Biol. 2000 Oct 15;226(2):220-30
pubmed: 11023682
Cell Rep. 2013 Jul 11;4(1):66-75
pubmed: 23831029
Dev Dyn. 1995 Jul;203(3):253-310
pubmed: 8589427
Am J Clin Oncol. 2019 Feb;42(2):184-189
pubmed: 30418178
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
Nature. 2004 Jan 15;427(6971):260-5
pubmed: 14712238
J Neurosci. 2008 Feb 27;28(9):2110-8
pubmed: 18305245
FASEB J. 2023 Jul;37(7):e23043
pubmed: 37342898
Biomed Res Int. 2015;2015:976068
pubmed: 26114119
Wound Repair Regen. 2019 Jul;27(4):375-385
pubmed: 31017740
Brain Res. 2007 Oct 12;1174:66-75
pubmed: 17868657
Development. 2008 Sep;135(18):3063-70
pubmed: 18701543
BMC Dev Biol. 2007 Jun 06;7:62
pubmed: 17553162
Front Mol Biosci. 2021 Sep 07;8:742903
pubmed: 34557523
Dev Cell. 2018 Aug 6;46(3):344-359.e4
pubmed: 30032992
J Neurosci. 2010 Jul 14;30(28):9359-67
pubmed: 20631165
Development. 1990 Oct;110(2):491-504
pubmed: 1723944
Development. 2006 Oct;133(19):3827-36
pubmed: 16943272
Development. 2012 Feb;139(3):591-600
pubmed: 22190641
Clin Cancer Res. 2006 Dec 15;12(24):7271-8
pubmed: 17189398
J Clin Oncol. 2010 Jan 20;28(3):398-404
pubmed: 20008620
J Neurosci. 2022 Jul 25;:
pubmed: 35882558
Ann Oncol. 2010 Jul;21(7):1559-1560
pubmed: 20444848
PLoS Biol. 2011 May;9(5):e1000621
pubmed: 21629674
Cancer Invest. 2003 Jun;21(3):439-51
pubmed: 12901290
Nat Neurosci. 2011 May;14(5):595-602
pubmed: 21460831
Development. 2007 Feb;134(3):611-23
pubmed: 17215310
Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2774-87
pubmed: 24091024
Proc Natl Acad Sci U S A. 2016 Apr 12;113(15):E2189-98
pubmed: 27035978
J Neurosci. 2013 Mar 20;33(12):5249-60
pubmed: 23516290
Science. 2016 Apr 8;352(6282):189-96
pubmed: 27124452
Development. 2000 Jul;127(13):2873-82
pubmed: 10851132
Neuron. 2022 Jun 1;110(11):1806-1821.e8
pubmed: 35349784
J Neurol Neurosurg Psychiatry. 2018 Jun;89(6):636-641
pubmed: 29439162
Proc Natl Acad Sci U S A. 2011 Mar 29;108(13):5425-30
pubmed: 21383146
Curr Cancer Drug Targets. 2022;22(1):49-76
pubmed: 34288840
Science. 2015 Apr 24;348(6233):453-7
pubmed: 25908823
Dev Neurobiol. 2013 Feb;73(2):152-67
pubmed: 22865660
Brain. 2021 Nov 29;144(10):3226-3238
pubmed: 33964142

Auteurs

Adam M Tuttle (AM)

Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, Oregon 97239.

Lauren N Miller (LN)

Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, Oregon 97239.

Lindsey J Royer (LJ)

Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, Oregon 97239.

Hua Wen (H)

Vollum Institute, Oregon Health & Science University, Portland, Oregon 97239.

Jimmy J Kelly (JJ)

Vollum Institute, Oregon Health & Science University, Portland, Oregon 97239.

Nicholas L Calistri (NL)

Biomedical Engineering, Oregon Health & Science University, Portland, Oregon 97239.

Laura M Heiser (LM)

Biomedical Engineering, Oregon Health & Science University, Portland, Oregon 97239.

Alex V Nechiporuk (AV)

Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, Oregon 97239 nechipor@ohsu.edu.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH